SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia with Venous Thrombosis, Pulmonary Embolism, and Adrenal Haemorrhage: A Case Report with Literature Review

Tews, Hauke Christian and Driendl, Sarah M. and Kandulski, Melanie and Buechler, Christa and Heiss, Peter and Stoeckert, Petra and Heissner, Klaus and Paulus, Michael G. and Kunst, Claudia and Mueller, Martina and Schmid, Stephan (2022) SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia with Venous Thrombosis, Pulmonary Embolism, and Adrenal Haemorrhage: A Case Report with Literature Review. VACCINES, 10 (4): 595. ISSN 2076-393X

Full text not available from this repository. (Request a copy)

Abstract

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with venous thrombosis is a rare complication of SARS-CoV-2 vaccination with ChAdOx1 (AstraZeneca) and AD26.COV2.S (Johnson & Johnson, New Brunswick, NJ, USA) associated with high mortality. At present, there are no known differences in the pathophysiology or risk factors of VITT with the AstraZeneca vaccine (ChAdOx1) compared with the Johnson & Johnson vaccine (AD26.COV2.S). Herein, we present the case of a healthy 39-year-old patient with VITT after having received the vaccine Ad26.COV2.S. Ten days after vaccination, the patient developed a deep vein thrombosis and subsequent pulmonary embolism. A computed tomography scan of the abdomen showed adrenal gland bleeding and an adrenocorticotrophic hormone stimulation test diagnosed adrenal insufficiency. Therapy with intravenous immunoglobulin, argatroban and hydrocortisone was initiated immediately after diagnosis. The patient left the hospital 22 days after admission with the diagnosis of adrenal insufficiency but otherwise in good health. To the best of our knowledge, five cases of VITT and adrenal bleeding have been described to date in the literature but the presented case was the first to occur after immunisation with the vaccine of Johnson & Johnson. In summary, VITT-associated adrenal dysfunction is a very rare complication of vaccination with an adenoviral vector-based COVID-19 vaccine.

Item Type: Article
Uncontrolled Keywords: SARS-CoV-2; COVID-19; vaccine; thrombocytopenia; VITT; adrenal insufficiency
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Medicine > Lehrstuhl für Innere Medizin II
Medicine > Lehrstuhl für Röntgendiagnostik
Depositing User: Petra Gürster
Date Deposited: 07 Sep 2023 06:48
Last Modified: 07 Sep 2023 06:48
URI: https://pred.uni-regensburg.de/id/eprint/56975

Actions (login required)

View Item View Item